Prof. Victor HF Lee is currently a Clinical Associate Professor at the Department of Clinical Oncology at the University of Hong Kong. He graduated from the University of Hong Kong in 2002. After his internship, he received post-graduate residency training in clinical oncology at Tuen Mun Hospital. He joined the Department of Clinical Oncology in 2008. He obtained his fellowship at the Royal College of Radiologists in Clinical Oncology in 2010. Afterward, he received further specialist training in interstitial brachytherapy for head and neck cancers and sarcoma at Institut Gustave Roussy in Paris, France, and novel radiation techniques like stereotactic radiosurgery and stereotactic ablative radiotherapy at Stanford University USA. In 2013, he received further training on stereotactic body radiation therapy for liver tumors at Princess Margaret Hospital, Canada. More recently in 2015, he was awarded the HKCR 15A Traveling Fellowship and pursued subspecialty training in image-guided brachytherapy for cervical cancer and pediatric oncology. His current interests include clinical and genetic studies on nasopharyngeal cancer, head and neck cancers, lung cancers, liver cancers, and gastrointestinal cancers. He has published extensively in these respects. In addition, he has a special interest in dosimetric studies on intensity-modulated radiation therapy, stereotactic radiosurgery, and selective internal radiation therapy with Yttrium-90 microspheres for liver tumors.
Prof. Victor HF Lee is currently a Clinical Associate Professor at the Department of Clinical Oncology at the University of Hong Kong. He graduated from the University of Hong Kong in 2002. After his internship, he received post-graduate residency training in clinical oncology at Tuen Mun Hospital. He joined the Department of Clinical Oncology in 2008. He obtained his fellowship at the Royal College of Radiologists in Clinical Oncology in 2010. Afterward, he received further specialist training in interstitial brachytherapy for head and neck cancers and sarcoma at Institut Gustave Roussy in Paris, France, and novel radiation techniques like stereotactic radiosurgery and stereotactic ablative radiotherapy at Stanford University USA. In 2013, he received further training on stereotactic body radiation therapy for liver tumors at Princess Margaret Hospital, Canada. More recently in 2015, he was awarded the HKCR 15A Traveling Fellowship and pursued subspecialty training in image-guided brachytherapy for cervical cancer and pediatric oncology. His current interests include clinical and genetic studies on nasopharyngeal cancer, head and neck cancers, lung cancers, liver cancers, and gastrointestinal cancers. He has published extensively in these respects. In addition, he has a special interest in dosimetric studies on intensity-modulated radiation therapy, stereotactic radiosurgery, and selective internal radiation therapy with Yttrium-90 microspheres for liver tumors.